This was also verified using STZ-induced diabetic rats, suggesting that activation of TRPV1 and the release of CGRP participate in diabetic vascular disease, and circulatory function directly affects peripheral neuropathy progress. The gene discussed is TRPV1; the disease is peripheral neuropathy.